On the stock market since 1987, it operates in the world of health and science. It has 2,003 employees. Now — the numbers.
This is an established company with proven profits.
That much dependence is a risk in itself: if this one line weakens, the whole company feels it directly.
Average growth of 15% a year over the last 4 years. Every year shown ended in profit.
If every debt were paid off today, $758.6M would still be left in the vault — a solid cushion for hard times.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Over the last 3 years, sales grew about 10% a year on average.
There is $758.6M in the vault; even if every debt were paid off, $758.6M would remain.
It met or beat analyst expectations in 6 of the last 6 quarters — consistency is a promise kept.
The company’s market value is 126 times its annual profit. Even a small disappointment could hit the price hard.
Over the last 12 months, executives reported 84 sells against just 13 buys. Not an alarm bell by itself, but a number worth watching.
On our five-subject report card, ABMD sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: ABMD is an established business that has proven its profits for years. The real debate isn’t the quality of the business — it’s whether the price paid for the stock is too high.